TUESDAY, DECEMBER 6, 2016

The Scripps Research Institute

130 Scripps Way
Jupiter, FL - 33458

The Scripps Research Institute News

New discoveries show promise for AIDS vaccine

Researchers from The Scripps Research Institute (TSRI), the International AIDS Vaccine Initiative (IAVI) and the La Jolla Institute for Allergy and Immunology recently discovered that an engineered vaccine protein bonds with important immune cells that are available in almost all humans, potentially helping create HIV antibodies naturally. Read More »

Scripps team discovers possible treatment for deadly viruses

The Scripps Research Institute (TSRI) Florida campus researchers have discovered a potential treatment that could protect people from serious viruses like West Nile, dengue and Ebola. Read More »

Scripps researchers study antibodies that fight HIV

Researchers at The Scripps Research Institute (TSRI) are studying the origins and ways antibodies that fight HIV develop, interact and fight HIV. Read More »

Scripps researchers find antibodies to develop HIV vaccine

Researchers from The Scripps Research Institute have discovered the origins of a group of antibodies that fight HIV, which may help them to develop a vaccine to protect people from contracting the virus. Read More »

Scripps researchers find compounds to treat tuberculosis

Researchers at The Scripps Research Institute (TSRI) have found some new compounds that may be the future of treating tuberculosis (TB). TB was been one of the leading killers throughout history. Read More »

Gates Foundation award to support Scripps research for HIV/AIDS vaccine

Scientists from the Jupiter, Florida campus of The Scripps Research Institute (TSRI) plan to use a new multi-million-dollar award to develop an HIV/AIDS alternative vaccine that has demonstrated potential in animal models. Read More »

Florida TSRI campus receives $6 million for alternative HIV/AIDS vaccine

Researchers from The Scripps Research Institute (TSRI) campus based in Florida have received approximately $6 million in awards from the Bill & Melinda Gates Foundation in order to further develop an innovative alternative HIV/AIDS vaccine. Read More »

Scripps awarded grant to study lupus and rheumatoid arthritis environmental triggers

Scientists at the Scripps Research Institute (SRI) recently accepted a grant that amounts to over $1.2 million to study the various environmental triggers that worsen lupus and rheumatoid arthritis symptoms. Read More »

Scripps study shows drug therapy candidate decreases HIV reactivation rate

Scientists from The Scripps Research Institute’s (TSRI) Florida campus said Wednesday they designed a drug candidate that significantly decreases the HIV reactivation site. Read More »

Chemists discover simple, thrifty method to synthesize amines

A team of chemists from the Scripps Research Institute (TSRI) recently discovered a simple and cost-efficient tool for synthesizing “amines,” which are a specific class of organic compounds that are commonly used in drugs and similar modern products. This discovery is especially useful as a method to synthesize complex amines that are valued in the pharmaceutical industry, but are difficult to synthesize with regular methods. Read More »

Novel synthetic compound may prevent type 1 diabetes

Scripps Research Institute study shows SR1001 prevents diabetes in animals. Read More »

New flu strains prove difficult to contract

A recent study by The Scripps Research Institute (TSRI) revealed evidence that two new influenza strains are not easy for humans to contract, making a pandemic unlikely. Read More »

Anti-HIV agent possibly efficient in vaccine form

Scientists have developed a drug that is so powerful against HIV that it may prove efficient as a vaccine. Read More »

Study helps explain how booster shots operate

A new Scripps Research Institute (TSRI) study helps shed light on how booster shots work to prompt immune “memory” to improve protection. Read More »